Objective: To identify risk factors among pregnant with COVID-
19 for adverse outcomes related to disease severity, maternal
morbidities, neonatal mortality and morbidity, and adverse birth
outcomes. Materials and methods: In this retrospective study,
45 pregnant patients with COVID-19 pneumonia confirmed by RT-PCR were
evaluated at HMIMV. The inclusion criteria were pregnant patients
diagnosed with COVID-19 confirmed by RT-PCR and hospitalized in the
gynecology-obstetrics and intensive care unit at Mohammed V Military
Training Hospital (HMIMV). Exclusion criteria were non-pregnant patients
and pneumonia cases with unconfirmed COVID-19 cause. Data was collected
from patient records and telephone calls. The study used SPSS
software to analyze the data. Results: Our study recorded 45
cases of SARS-CoV-2 infection in pregnant women over 2.5 years in the
gynecology-obstetrics department at HMIMV. The age group most affected
was 20-35 years, with 75% of cases. 57% of patients had no known
comorbidities. 88.8% of patients were symptomatic at diagnosis, with
fever, asthenia, headache, myalgia, anosmia, and ageusia being the most
common symptoms. Almost 30% of patients required admission to the ICU,
with 60% requiring oxygen supplementation. The study recorded 36 live
births (80%), of which 26 cases (72.2%) required no further care and
had a favorable outcome. Conclusion: Severe acute respiratory
distress syndrome, which can be fatal, is a significant risk associated
with COVID-19. Pregnant women with underlying medical conditions are
more vulnerable to this complication and may benefit from preventive
measures, such as lockdowns, to reduce their risk of infection. The
severity of maternal disease appears to have an impact on obstetrical
and neonatal outcomes, with potential complications including cesarean
sections, neonatal prematurity, and admission to the intensive care unit
.